Accord Healthcare

Accord Healthcare is a pharmaceutical company specializing in generic and biosimilar medicines. The company develops and delivers affordable treatment options across multiple therapeutic areas including oncology, autoimmune diseases, and central nervous system disorders.

Source: https://www.accord-healthcare.com

serplulimabHetronifly

PD-1 checkpoint inhibitor

Hetronifly (serplulimab) is a PD-1 checkpoint inhibitor from Accord Healthcare used in the European Union with chemotherapy as first-line treatment for extensive-stage small cell lung cancer, non-squamous non-small cell lung cancer without EGFR, ALK, or ROS1 mutations, and PD-L1-positive esophageal squamous cell carcinoma.

Serplulimab is a monoclonal antibody given by intravenous infusion that targets PD-1, an off-switch expressed on T cells. Many cancers display the lig

1 medicine explained